curculigoside has been researched along with cytochrome c-t in 1 studies
| Studies (curculigoside) | Trials (curculigoside) | Recent Studies (post-2010) (curculigoside) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 37 | 0 | 32 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Guo, Y; Jia, D; Liu, S; Wu, N; Zhao, Y | 1 |
1 other study(ies) available for curculigoside and cytochrome c-t
| Article | Year |
|---|---|
Curculigoside attenuates myocardial ischemia‑reperfusion injury by inhibiting the opening of the mitochondrial permeability transition pore.
Topics: Animals; Apoptosis; Benzoates; Caspase 3; Caspase 9; Cell Survival; Cells, Cultured; Cytochromes c; Glucosides; Hypoxia; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar | 2020 |